Genpact Down 40%: AI Disruption Priced Into Valuation

Genpact shares have lost 40% of their value this year. The decline mirrors a broad selloff in business process outsourcing stocks. Investors fear that AI agents will automate the simple, rules-based tasks that have long been the industry's core revenue driver.

The concern is straightforward. Large language models can handle invoice processing, data entry, and basic customer service scripts at a fraction of the cost of a human team. If that substitution happens quickly, the labor-arbitrage model that built Genpact over two decades starts to crack. The selloff has been indiscriminate. WNS and ExlService are down similar amounts, even though their exposure to AI-vulnerable work varies.

Genpact management has acknowledged the risk. On the last earnings call, CEO Balkrishan Kalra said the company is investing in AI-led transformation for clients. That shift could mean lower revenue per contract in the short term as automation replaces headcount-based billing. The stock now trades at roughly 12 times forward earnings. That is a steep discount to its five-year average of 18 times. The company generates about $500 million in free cash flow over the trailing twelve months and carries net cash on the balance sheet.

The key question is whether the market is correctly discounting a structural decline or overcorrecting for a transition that will take years to play out. AI adoption in enterprise outsourcing has been slower than the hype suggests. Most large clients run legacy systems that are not easily plugged into an API. Integration, data security, and regulatory compliance create friction that a chatbot alone cannot solve. Genpact's deep domain expertise in finance and accounting processes, built over two decades of running back offices for Fortune 500 companies, is not something a generic AI model replicates overnight.

The bull case rests on Genpact becoming a beneficiary of the same technology that threatens it. If the company can package AI tools into its service offerings and charge for outcomes rather than headcount, margins could expand even as revenue per employee falls. The bear case is that clients will eventually bypass Genpact entirely and license AI software directly from Microsoft or Salesforce.

The 40% decline prices in a lot of bad news. At 12x forward earnings, the stock is cheaper than 90% of its history. The discount to historical multiples implies the market expects a permanent reduction in earnings power. Whether that expectation is correct depends on how quickly the transition happens and whether Genpact can prove it is part of the solution, not just another legacy vendor facing disruption.